New York, January 16, 2020: Next generation sequencing is a method of DNA sequencing to determine the appropriate order of nucleotides within a DNA molecule. Next generation sequencing technology enables speedy sequencing and produces million of DNA and RNA series with using next technology sequencer. Next generation sequencing (NGS) is likewise called high-throughput sequencing. NGS has range of different new sequencing technologies inclusive of illumina sequencing and roche 454 sequencing. NGS affords a low price and high throughput opportunity for sequencing DNA as compare to conventional Sanger sequencing. NGS provides its offerings in the studies subject such as metagenomics, cancers research, genetic ailment research and newborn sequencing. Numerous NGS systems provide low cost and excessive throughput sequencing such as illuminamiseq, lifestyles technologies ion proton and individual genome machine.
The scope of the report includes a detailed study of global and regional markets for Global Next Generation Sequencing NGS Market with the reasons given for variations in the growth of the industry in certain regions.
You Can Find Full Report Here: https://www.marketresearchengine.com/reportdetails/next-generation-sequencing-ngs-market
The Global Next Generation Sequencing NGS Market is expected to exceed more than US$ 16.0 Billion by 2024 and will grow at a CAGR of more than 20% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pacific Biosciences, Beijing Genomics Institute, Illumina Inc., 454 Life Sciences Corp. (Roche Holding Ag), GATC Biotech Ag., Life Technologies (Thermo Fisher Scientific), Oxford Nanopore Technologies Inc., Agilent Technologies Inc., Biomatters Ltd., Dnastar Inc., Macrogen Inc., HelicosBioSciences, Clc Bio (Qiagen), and Knome Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Next Generation Sequencing NGS Market is segmented on the lines of its workflow, application, end user, technology and regional. Based on workflow segmentation it covers NGS pre sequencing, NGS data analysis and NGS sequencing. Under application segmentation it covers HLA testing, oncology, prenatal testing, idiopathic diseases and infectious diseases. Based on end user segmentation it covers academic research, hospitals & clinics, clinical research, pharma & biotech entities and other users. Technology is classified into whole genome sequencing, whole exome sequencing, targeted sequencing and resequencing. The Global Next Generation Sequencing NGS Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The Global Next Generation Sequencing NGS Market has been segmented as below:
The Global Next Generation Sequencing NGS Market is Segmented on the lines of Workflow Analysis, Application Analysis, End User Analysis, Technology Analysis and Regional Analysis. By Workflow Analysis this market is segmented on the basis of NGS Pre-Sequencing, NGS Data Analysis and NGS Sequencing. By Application Analysis this market is segmented on the basis of HLA Testing, Oncology, Prenatal Testing, Idiopathic Diseases and Infectious Diseases.
By End User Analysis this market is segmented on the basis of Academic Research sector, Hospitals & Clinics sector, Clinical Research sector, Pharma & Biotech Entities sector and Other users sectors. By Technology Analysis this market is segmented on the basis of Whole genome sequencing, Whole exome sequencing and Targeted sequencing and resequencing. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
The major driving factors of Global Next Generation Sequencing NGS Market are as follows:
• Falling price for genetic sequencing
• Increasing related progress of personalized medicine
• Rising prevalence of cancer
• Increase competition among prominent market entities
The restraining factors of Global Next Generation Sequencing NGS Market are as follows:
• Nonvalue based NGS reimbursement strategy
This report provides:
1) An overview of the global market for Next Generation Sequencing NGS and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Next Generation Sequencing NGS Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/next-generation-sequencing-ngs-market
Table of Contents
2 Research Methodology
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary and Primary Research Methodology
2.3.1 Secondary Research
22.214.171.124 Key Data From Secondary Sources
2.3.2 Primary Data
126.96.36.199 Breakdown of Primaries
188.8.131.52 Key Data From Primary Sources
184.108.40.206 Key Industry Insights
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Next-Generation Sequencing Market, By Product & Service
7 Next-Generation Sequencing Market, By Technology
8 Next-Generation Sequencing Market, By Application
9 Next-Generation Sequencing Market, By End User
10 Next-Generation Sequencing Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1.1 Geographic Benchmarking
12.2 Illumina, Inc.
12.3 Thermo Fisher Scientific Inc.
12.4 Pacific Biosciences of California, Inc.
12.5 Qiagen N.V.
12.6 Beijing Genomics Institute
12.7 Perkinelmer, Inc.
12.8 F. Hoffmann-La Roche AG
12.9 Agilent Technologies, Inc.
12.10 Gatc Biotech AG
12.11 Oxford Nanopore Technologies, Ltd.
12.12 Macrogen, Inc.
12.13 Eurofins Scientific
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States